Violation Tracker Agency Summary Page
Agency Name:
Multistate Attorneys General Case
Penalty Total since 2000:
$111,395,268,927
Number of Records:
680
Note:
The penalty total above and the parent totals below include some cases in which both a state and a federal agency were involved and issued separate announcements of the outcome. The individual penalty records below marked by an asterisk are ones for which Violation Tracker contains a separate federal entry.
| Top 10 Parent Companies | Total Penalty $ | Number of Records |
|---|---|---|
| Bank of America | $26,114,848,408 | 10 |
| UBS | $11,393,380,000 | 5 |
| Citigroup | $8,235,591,577 | 7 |
| JPMorgan Chase | $6,208,338,661 | 10 |
| BP | $4,910,000,000 | 2 |
| American Electric Power | $4,687,500,000 | 3 |
| Morgan Stanley | $4,060,100,000 | 4 |
| Goldman Sachs | $3,690,833,333 | 3 |
| Deutsche Bank | $3,648,333,333 | 3 |
| Wells Fargo | $1,872,683,716 | 8 |
Individual Penalty Records:
Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.
| Company | Parent | Parent Major Industry |
Primary Offense Type |
Year | Penalty Amount |
|---|---|---|---|---|---|
| Medicis Pharmaceutical Corporation | Bausch Health | pharmaceuticals | off-label or unapproved promotion of medical products | 2007 | (*) $4,000,000 |
| Merck Sharp & Dohme Corp. | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | (*) $201,975,000 |
| Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | (*) $88,258,694 |
| Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | (*) $29,000,000 |
| Novo Nordisk Inc. | Novo Holdings A/S | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | (*) $3,574,209 |
| Organon | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | $31,000,000 |
| Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | (*) $24,681,516 |
| Otsuka American Pharmaceutical Inc. | Otsuka Pharmaceutical | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | (*) $1,700,000 |
| Par Pharmaceutical Companies Inc. | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | (*) $22,500,000 |
| Pfizer | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | $35,000,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | $60,000,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | $42,900,000 |
| Purdue Pharma | Purdue Pharma | pharmaceuticals | off-label or unapproved promotion of medical products | 2007 | $19,500,000 |
| Schering-Plough Corporation | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2006 | (*) $91,602,000 |
| Serono Inc. | Merck KGaA (EMD) | pharmaceuticals | off-label or unapproved promotion of medical products | 2005 | (*) $262,000,000 |
| Shire Pharmaceuticals LLC | Takeda Pharmaceutical | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | (*) $20,786,034 |
| UCB Inc. | UCB | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | (*) $9,893,322 |
| Warner-Lambert | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2004 | (*) $190,000,000 |
| Wyeth Pharmaceuticals, Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | (*) $257,400,000 |
| McKinsey & Company | McKinsey | business services | off-label or unapproved promotion of medical products | 2021 | $573,000,000 |
| Abbott Laboratories | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | $15,350,000 |
| Abbott Laboratories and Fournier Industrie et Sante and Laboratoires Fournier S.A. | Abbott Laboratories | pharmaceuticals | price-fixing or anti-competitive practices | 2010 | $22,500,000 |
| ACE Group Holdings, Inc. | Chubb Limited | financial services | price-fixing or anti-competitive practices | 2007 | $4,500,000 |
| ACE, Ltd | Chubb Limited | financial services | price-fixing or anti-competitive practices | 2006 | $80,000,000 |
| Akzo Nobel Inc. | Akzo Nobel | paints and coatings | price-fixing or anti-competitive practices | 2009 | $2,275,454 |
| Alpharma, Inc. | Pfizer | pharmaceuticals | price-fixing or anti-competitive practices | 2004 | $750,000 |
| American International Group, Inc. | American International Group | financial services | price-fixing or anti-competitive practices | 2008 | $12,500,000 |
| Andrx Corporation | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | $40,000,000 |
| Aon Corporation | Aon | financial services | price-fixing or anti-competitive practices | 2005 | $190,000,000 |
| Apple Inc. | Apple Inc. | electrical and electronic equipment | price-fixing or anti-competitive practices | 2014 | $450,000,000 |
| AU Optronics Corporation | AU Optronics | electrical and electronic equipment | price-fixing or anti-competitive practices | 2012 | $170,000,000 |
| Aventis Animal Nutrition | price-fixing or anti-competitive practices | 2000 | $20,721,300 | ||
| Aventis Pharmaceuticals Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | $40,000,000 |
| Aventis Pharmaceuticals, Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | $1,650,000 |
| Bank of America | Bank of America | financial services | price-fixing or anti-competitive practices | 2010 | (*) $67,000,000 |
| Barr Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2008 | $5,900,000 |
| BASF Corporation | BASF | chemicals | price-fixing or anti-competitive practices | 2000 | $62,258,250 |
| Bausch & Lomb | Bausch Health | pharmaceuticals | price-fixing or anti-competitive practices | 2001 | $17,500,000 |
| Bertelsmann Music Group Inc. | Sony | electrical and electronic equipment | price-fixing or anti-competitive practices | 2003 | $27,775,000 |
| Bioproducts Incorporated | price-fixing or anti-competitive practices | 2009 | $2,275,454 | ||
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | $55,000,000 |
| Bristol-Myers Squibb Co. | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | $100,000,000 |
| Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2008 | $1,100,000 |
| Chimei Innolux Corp. | Chi Mei Corporation | chemicals | price-fixing or anti-competitive practices | 2011 | $110,273,318 |
| Chinook Global Limited | price-fixing or anti-competitive practices | 2009 | $2,275,454 | ||
| Chubb | Chubb Limited | financial services | price-fixing or anti-competitive practices | 2006 | $17,000,000 |
| Chunghwa Picture Tubes Ltd. | Tatung | electrical and electronic equipment | price-fixing or anti-competitive practices | 2011 | $5,305,105 |
| CIBA Vision | Novartis | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | $5,000,000 |
| Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | $4,340,100 |
| E*Trade | Morgan Stanley | financial services | price-fixing or anti-competitive practices | 2012 | $100,000 |
| Eisai | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | $7,634,700 |
| Elpida Memory Inc. | Micron Technology | electrical and electronic equipment | price-fixing or anti-competitive practices | 2010 | $4,259,948 |
| EMI Music Distribution | Sony | electrical and electronic equipment | price-fixing or anti-competitive practices | 2003 | $15,000,000 |
| Encore Paper Co. | price-fixing or anti-competitive practices | 2000 | $300,000 | ||
| Endo International plc | Endo International | pharmaceuticals | price-fixing or anti-competitive practices | 2019 | $2,300,000 |
| Epson | Seiko Group | electrical and electronic equipment | price-fixing or anti-competitive practices | 2011 | $2,850,000 |
| Evonik Degussa GmbH | Evonik Industries | chemicals | price-fixing or anti-competitive practices | 2009 | $2,275,454 |
| Ferring B.V. | price-fixing or anti-competitive practices | 2012 | $1,800,000 | ||
| First Group, plc | FirstGroup | miscellaneous services | price-fixing or anti-competitive practices | 2007 | $1,100,000 |
| Fort James Corp. | Koch Industries | diversified | price-fixing or anti-competitive practices | 2000 | $300,000 |
| GE Funding Capital Market Services, Inc. | General Electric | diversified | price-fixing or anti-competitive practices | 2011 | (*) $34,250,000 |
| Geneva Pharmaceuticals | Novartis | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | $15,350,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2006 | $14,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2006 | $3,500,000 |
| Hachette Book Group Inc. | price-fixing or anti-competitive practices | 2013 | $34,791,666 | ||
| HannStar Display Corporation | HannStar Display | electrical and electronic equipment | price-fixing or anti-competitive practices | 2011 | $25,650,000 |
| HarperCollins Publishers LLC | News Corp. | media | price-fixing or anti-competitive practices | 2013 | $22,471,666 |
| Hartford Financial Services Group, Inc. | Hartford Financial Services | financial services | price-fixing or anti-competitive practices | 2007 | $115,000,000 |
| Healthcare Research and Development Institute, LLC | price-fixing or anti-competitive practices | 2007 | $150,000 | ||
| Herman Miller, Inc. | Herman Miller Inc. | miscellaneous manufacturing | price-fixing or anti-competitive practices | 2008 | $750,000 |
| Hitachi, Ltd. | Hitachi | diversified | price-fixing or anti-competitive practices | 2011 | $38,977,224 |
| Hoffman-LaRoche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | $142,494,000 |
| Holtzbrinck Publishers LLC dba MacMillan | price-fixing or anti-competitive practices | 2014 | $26,250,000 | ||
| Hynix Semiconductor, Inc. | SK Holdings | electrical and electronic equipment | price-fixing or anti-competitive practices | 2010 | $49,971,842 |
| Infineon Technologies A.G. | Infineon Technologies | electrical and electronic equipment | price-fixing or anti-competitive practices | 2010 | $29,113,776 |
| Johnson & Johnson Vision Care, Inc. | Johnson & Johnson | pharmaceuticals | price-fixing or anti-competitive practices | 2001 | $60,000,000 |
| JPMorgan Chase | JPMorgan Chase | financial services | price-fixing or anti-competitive practices | 2011 | (*) $75,000,000 |
| Kimberly-Clark Corp. | Kimberly-Clark | household and personal care products | price-fixing or anti-competitive practices | 2000 | $300,000 |
| LG Display Co., Ltd. | LG | diversified | price-fixing or anti-competitive practices | 2012 | $380,000,000 |
| Lonza AG | Lonza | chemicals | price-fixing or anti-competitive practices | 2009 | $2,275,454 |
| Mallinckrodt plc | Mallinckrodt | pharmaceuticals | price-fixing or anti-competitive practices | 2017 | (*) $100,000,000 |
| Marcal Paper Mills Co. | price-fixing or anti-competitive practices | 2000 | $300,000 | ||
| Marsh & McLennan Companies, Inc. | Marsh & McLennan | financial services | price-fixing or anti-competitive practices | 2005 | $850,000,000 |
| Marsh and McLennan | Marsh & McLennan | financial services | price-fixing or anti-competitive practices | 2009 | $7,000,000 |
| Merck KGaA | Merck KGaA (EMD) | pharmaceuticals | price-fixing or anti-competitive practices | 2009 | $2,275,454 |
| Micron Technology, Inc. | Micron Technology | electrical and electronic equipment | price-fixing or anti-competitive practices | 2010 | $66,774,984 |
| Mitsubishi Tanabe Pharma Corporation | Mitsubishi Group | diversified | price-fixing or anti-competitive practices | 2009 | $2,275,454 |
| Mosel-Vitelic Corp. | price-fixing or anti-competitive practices | 2010 | $2,778,900 | ||
| Musicland Stores Corp. | Best Buy | retailing | price-fixing or anti-competitive practices | 2003 | $2,000,000 |
| Mylan Laboratories et al. | Viatris | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | (*) $108,000,000 |
| National Football League | price-fixing or anti-competitive practices | 2016 | $100,000 | ||
| Natixis Funding Corp. | Natixis | financial services | price-fixing or anti-competitive practices | 2016 | $29,950,000 |
| NEC Electronics America, Inc. | NEC Corp. | information technology | price-fixing or anti-competitive practices | 2010 | $20,277,350 |
| Nepera, Inc. | price-fixing or anti-competitive practices | 2009 | $2,275,454 | ||
| New Times Media | price-fixing or anti-competitive practices | 2003 | $375,000 | ||
| Nine West Group Inc. | Premier Brands Group Holdings | apparel | price-fixing or anti-competitive practices | 2000 | (*) $34,000,000 |
| Organon USA Inc | Merck | pharmaceuticals | price-fixing or anti-competitive practices | 2004 | $36,000,000 |
| Penguin Group (USA) Inc. | Bertelsmann | media | price-fixing or anti-competitive practices | 2014 | $90,000,000 |
| Perrigo Company | Perrigo | pharmaceuticals | price-fixing or anti-competitive practices | 2004 | $750,000 |
| Salton Inc. | Spectrum Brands Holdings | housewares and home furnishings | price-fixing or anti-competitive practices | 2002 | $8,200,000 |
| Samsung Electronics, Co., Ltd. | Samsung | diversified | price-fixing or anti-competitive practices | 2011 | $240,000,000 |
